Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Kirsten De Ridder actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma
De Beck, L., Awad, R. M., Basso, V., Casares, N., De Ridder, K., De Vlaeminck, Y., Gnata, A., Goyvaerts, C., Lecocq, Q., San José-Enériz, E., Verhulst, S., Maes, K., Vanderkerken, K., Agirre, X., Prosper, F., Lasarte, J. J., Mondino, A. & Breckpot, K., 12 mei 2022, In: Frontiers in Immunology. 13, 15 blz., 799636.Onderzoeksoutput: Article › peer review
Open Access -
Novel 3D Lung Tumor Spheroids for Oncoimmunological Assays
De Ridder, K., Tung, N., Werle, J-T., Karpf, L., Awad, R. M., Bernier, A., Ceuppens, H., Salmon, H. & Goyvaerts, C., apr 2022, In: Advanced Nanobiomed Research. 2, 4Onderzoeksoutput: Article › peer review
Open AccessBestand23 Downloads (Pure) -
Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model
Ertveldt, T., De Beck, L., De Ridder, K., Locy, H., De Mey, W., Goyvaerts, C., Lecocq, Q., Ceuppens, H., De Vlaeminck, Y., Awad, R. M., Keyaerts, M., Devoogdt, N., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., jul 2022, In: Molecular Cancer Therapeutics. 21, 7, blz. 1136-1148 13 blz.Onderzoeksoutput: Article › peer review
Open Access -
TNF-alpha-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy
De Ridder, K., Locy, H., Piccioni, E., Zuazo, M. I., Awad, R. M., Verhulst, S., Van Bulck, M., De Vlaeminck, Y., Lecocq, Q., Reijmen, E., De Mey, W., De Beck, L., Ertveldt, T., Pintelon, I., Timmermans, J-P., Escors, D., Keyaerts, M., Breckpot, K. & Goyvaerts, C., 14 apr 2022, In: Frontiers in Immunology. 13, 15 blz., 811867.Onderzoeksoutput: Article › peer review
Open AccessBestand1 Citaat (Scopus)13 Downloads (Pure) -
Combining dual G9a/DNMTs epigenetic inhibition and immunotherapy to treat metastatic melanoma
De Beck, L., Awad, R. M., De Vlaeminck, Y., Basso, V., Casares, N., Verhulst, S., San José-Enériz, E., De Ridder, K., Goyvaerts, C., Maes, K., Vanderkerken, K., Agirre, X., Prosper, F., Lasarte, J. J., Mondino, A. & Breckpot, K., 11 feb 2021, blz. 1. 1 blz.Onderzoeksoutput: Unpublished abstract
2 Downloads (Pure)
Activiteiten
- 5 Talk or presentation at a conference
-
Combining dual G9a/DNMTs epigenetic inhibition and immunotherapy to treat metastatic melanoma
Lien De Beck (Speaker), Robin Maximilian Awad (Contributor), Yannick De Vlaeminck (Contributor), Veronica Basso (Contributor), Noelia Casares (Contributor), Stefaan Verhulst (Contributor), Edurne San José-Enériz (Contributor), Kirsten De Ridder (Contributor), Cleo Goyvaerts (Contributor), Ken Maes (Contributor), Karin Vanderkerken (Contributor), Xabier Agirre (Contributor), Filipe Prosper (Contributor), Juan José Lasarte (Contributor), Anna Mondino (Contributor) & Karine Breckpot (Contributor)
11 feb 2021Activiteit: Talk or presentation at a conference
-
Lung tumor spheroids to assess immunological assets of the tumor microenvironment.
Kirsten De Ridder (Speaker)
17 mei 2021 → 21 mei 2021Activiteit: Talk or presentation at a conference
-
Poster presentation: Functional impact of anti-PD-L1 treatment on specific lung (tumor) residing myeloid cell subsets.
Kirsten De Ridder (Speaker)
7 feb 2020Activiteit: Talk or presentation at a conference
-
Oral presentation: Turn back the TIMe of Tumor Infiltrating Myeloid cells in non-small cell lung cancer.
Kirsten De Ridder (Speaker)
7 mei 2019Activiteit: Talk or presentation at a conference
-
Poster presentation: Functional impact of anti-PD-L1 treatment on specific lung (tumor) residing myeloid cell subsets.
Kirsten De Ridder (Speaker)
18 okt 2019Activiteit: Talk or presentation at a conference